Intuitive Surgical, Inc. $ISRG is Seilern Investment Management Ltd’s 8th Largest Position

Seilern Investment Management Ltd lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 115,695 shares of the medical equipment provider’s stock after purchasing an additional 17,337 shares during the quarter. Intuitive Surgical comprises 5.8% of Seilern Investment Management Ltd’s investment portfolio, making the stock its 8th biggest holding. Seilern Investment Management Ltd’s holdings in Intuitive Surgical were worth $46,010,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norway Savings Bank lifted its position in Intuitive Surgical by 2.5% during the second quarter. Norway Savings Bank now owns 3,253 shares of the medical equipment provider’s stock valued at $1,294,000 after buying an additional 78 shares during the period. Gradient Investments LLC grew its position in shares of Intuitive Surgical by 30.0% in the 2nd quarter. Gradient Investments LLC now owns 47,640 shares of the medical equipment provider’s stock worth $18,945,000 after buying an additional 10,988 shares during the period. Czech National Bank increased its stake in shares of Intuitive Surgical by 4.2% in the 2nd quarter. Czech National Bank now owns 100,808 shares of the medical equipment provider’s stock worth $40,089,000 after acquiring an additional 4,090 shares in the last quarter. PensionDanmark Pensionsforsikringsaktieselskab lifted its position in Intuitive Surgical by 15.9% during the 2nd quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 67,208 shares of the medical equipment provider’s stock valued at $26,727,000 after acquiring an additional 9,212 shares during the period. Finally, Apella Capital LLC lifted its position in Intuitive Surgical by 38.7% during the 2nd quarter. Apella Capital LLC now owns 1,229 shares of the medical equipment provider’s stock valued at $525,000 after acquiring an additional 343 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 1.4%

NASDAQ:ISRG opened at $378.81 on Friday. The company’s 50 day moving average price is $392.87 and its 200-day moving average price is $445.78. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a market cap of $133.83 billion, a price-to-earnings ratio of 43.39, a PEG ratio of 2.74 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.81 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research note on Tuesday, June 2nd. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, Stifel Nicolaus cut their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $509.02.

Insiders Place Their Bets

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 6,634 shares of company stock valued at $2,796,795. Corporate insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.